News for Penumbra, Inc. (PEN)

Shares of Penumbra Inc (PEN) fell 3.53% in mid-day trading on Feb 25. The stock reached an intraday low of $275.27, before recovering slightly to $277.54, d

Penumbra Inc (PEN), a leading company in the thrombectomy sector, announced on February 21, 2025, that Don Kassing will retire from its board of directors effec

Penumbra (PEN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

U.S. stocks were lower, with the Dow Jones falling over 200 points on Wednesday. Shares of Garmin Ltd. GRMN rose sharply during Wednesday's session after the c...

Penumbra reports better-than-expected earnings and revenues in the fourth quarter of 2024.

Revenue: $321.3 million for Q4 2024, a 12.9% increase year over year on an adjusted basis.Full Year Revenue: Over $1.2 billion, a 13.4% increase year over year

Feb 18, 2025 / 09:30PM GMTOperator Good afternoon. My name is Rob, and I will be your conference operator today. At this time, I would like to welcome everyone

Discover key insights from Penumbra’s Q4 2024 earnings call: 12.9% revenue growth, strong thrombectomy performance, new product launches & 2025 strategic...

Penumbra, Inc. (NYSE:PEN) Q4 2024 Earnings Conference Call February 18, 2025 4:30 PM ETCompany ParticipantsCecilia Furlong - Director of Business...

The headline numbers for Penumbra (PEN) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Penumbra (PEN) Q4 earnings announcement is set for Feb 18. Explore consensus estimates, past performance, and recent revisions for insights.

PEN continues to attract investor interest with its strong portfolio expansion and global expansion efforts.

Penumbra Inc (PEN), a leading thrombectomy company, has announced that it will host a conference call to discuss its financial results for the fourth quarter an

PR NewswireALAMEDA, Calif., Jan. 21, 2025 ALAMEDA, Calif., Jan. 21, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a con

UBS has initiated coverage of Penumbra (PEN) with a buy rating, citing its growth potential. Read more here.

Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiation...

Penumbra (PEN) is well positioned to outperform the market, as it exhibits above-average growth in financials.

YPF Sociedad, Telefonica, Penumbra, Deckers Outdoor and Abercrombie & Fitch have been highlighted in this Screen of The Week article.

Penumbra (PEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.